Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$56.61 - $80.46 $127,825 - $181,678
-2,258 Closed
0 $0
Q1 2021

May 18, 2021

SELL
$86.23 - $125.19 $381,653 - $554,090
-4,426 Reduced 66.22%
2,258 $209,000
Q4 2020

Feb 16, 2021

BUY
$79.17 - $111.47 $50,589 - $71,229
639 Added 10.57%
6,684 $598,000
Q3 2020

Nov 16, 2020

SELL
$81.91 - $134.94 $59,139 - $97,426
-722 Reduced 10.67%
6,045 $624,000
Q2 2020

Aug 14, 2020

SELL
$54.33 - $89.52 $6,899 - $11,369
-127 Reduced 1.84%
6,767 $535,000
Q4 2019

Feb 12, 2020

SELL
$51.21 - $59.06 $26,014 - $30,002
-508 Reduced 6.86%
6,894 $371,000
Q3 2019

Nov 14, 2019

BUY
$40.6 - $57.2 $2,273 - $3,203
56 Added 0.76%
7,402 $386,000
Q2 2019

Aug 13, 2019

SELL
$39.92 - $53.86 $24.2 Million - $32.7 Million
-606,923 Reduced 98.8%
7,346 $354,000
Q1 2019

May 14, 2019

BUY
$48.23 - $66.16 $4.74 Million - $6.5 Million
98,264 Added 19.04%
614,269 $31 Million
Q4 2018

Feb 14, 2019

SELL
$55.63 - $73.24 $15.7 Million - $20.6 Million
-281,403 Reduced 35.29%
516,005 $30.6 Million
Q3 2018

Nov 15, 2018

SELL
$52.05 - $66.51 $7 Million - $8.95 Million
-134,549 Reduced 14.44%
797,408 $52.5 Million
Q2 2018

Aug 15, 2018

SELL
$48.33 - $55.64 $2.49 Million - $2.86 Million
-51,473 Reduced 5.23%
931,957 $47.1 Million
Q4 2017

Feb 15, 2018

SELL
$37.77 - $47.75 $20 Million - $25.3 Million
-528,961 Reduced 34.98%
983,430 $45.7 Million
Q3 2017

Nov 14, 2017

BUY
$34.14 - $40.45 $51.6 Million - $61.2 Million
1,512,391
1,512,391 $0

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $438M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Glenmede Trust CO Na Portfolio

Follow Glenmede Trust CO Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.